Intermountain Health Care   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Salt Lake City UT United States (1970)

Organization Overview

First Clinical Trial
2002
NCT00309712
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Intermountain Clinical Research | Intermountain Health Care (IHC) LDS Hospital | Intermountain Health Care (IHC) McKay-Dee Hospital | Intermountain Health Care, Inc. | Intermountain Healthcare, LDS Hospital | Samuel Brown

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Habitual (Phase 2)

Abortion, Spontaneous (Phase 2)

Acute Kidney Injury (Phase 1)

Antiphospholipid Syndrome (Phase 4)

Atrial Fibrillation (Phase 4)

Cognition Disorders (Phase 4)

Cognitive Dysfunction (Phase 4)

Coronary Artery Disease (Phase 4)

Critical Illness (Phase 1)

Dementia (Phase 4)

Fetal Death (Phase 2)

Heart Failure (Phase 2)

Infarction (Phase 4)

Infections (Phase 2)

Kidney Tubular Necrosis, Acute (Phase 1)

Myocardial Infarction (Phase 4)

Necrosis (Phase 1)

Pancreatic Diseases (Phase 3)

Pancreatic Neoplasms (Phase 3)

Shock (Phase 2)

Shock, Septic (Phase 2)

Stroke (Phase 4)

Syndrome (Phase 4)

Thromboembolism (Phase 4)

Thrombosis (Phase 4)

Venous Thromboembolism (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 36
  • # of Trial APIs: 33